Literature DB >> 29576707

Novel Method of Preparation and Activity Research on Arctigenin from Fructus Arctii.

Enbo Cai1, Jiahong Han1, Limin Yang1, Weiyuan Zhang1, Yan Zhao1, Qiulian Chen1, Meng Guo1, Xinhong He1.   

Abstract

BACKGROUND: Arctigenin has many pharmacological activities with clinical significance and is derived from Arctium lappa L. However, the present extraction method is inefficient and does not have meaningful industrial production.
OBJECTIVE: A new method to directly prepare arctigenin was established by combining enzyme-assisted extraction and central composite design. Arctigenin's further pharmacological activity was also surveyed in vitro.
MATERIALS AND METHODS: β-D-Glucosidase, a food-grade enzyme, was added directly to the fruits of A. lappa L. to hydrolyze the arctiin to arctigenin, and the obtained samples were subsequently subjected to ethanol (30%, v/v) extraction. The pharmacological activity of the extraction and arctigenin was determined by inhibiting acetylcholinesterase (AChE) and scavenging nitrite.
RESULTS: The factors investigated include the enzyme concentration (0.5%-2.5%), ultrasound time (10 min-3 0 min), and extraction temperature (30°C-50°C). From the analysis of the results by Design-Expert (V8.0.6), the optimal extraction conditions were obtained: enzyme concentration (1.4%), ultrasound time (25 min), and extraction temperature (45°C). The highest yield of arctigenin, obtained under the optimal conditions was 6.39%, representing an increase of 28.15% compared to the reference extraction without enzyme processing. The IC50 values of the extraction and arctigenin, respectively, for inhibiting AChE were 0.572 mg/ml and 0.462 mg/ml, and those for nitrite-scavenging were 34.571 mg/ml and 17.49 mg/ml.
CONCLUSIONS: The results demonstrate that using an enzyme directly in the production is an effective means for extracting arctigenin from Fructus arctii. The extraction has the activities of inhibiting AChE and scavenging nitrite, probably because there has arctigenin in it. It is implied that the extraction and arctigenin could contribute to human health in clinical applications.
SUMMARY: The new method of adding enzyme directly to the preparation of arctigenin was carried out instead of preparing arctigenin by two-step methodThree factors affecting the efficiency of preparation were analyzed and discussed include the enzyme concentration, ultrasound time, and extraction temperature by central composite designThis new method of preparing arctigenin improved the yield significantly than other methodsArctigenin has remarkable pharmacological activities of inhibiting acetylcholinesterase and scavenging nitrite. Abbreviations used: AChE: Acetylcholinesterase, CCD: Central composite design, TCM: Traditional Chinese medicines, AD.

Entities:  

Keywords:  Arctigenin; Fructus arctii; enzyme-assisted extraction; inhibiting acetylcholinesterase activity; nitrite-scavenging activity; response surface

Year:  2018        PMID: 29576707      PMCID: PMC5858248          DOI: 10.4103/pm.pm_514_16

Source DB:  PubMed          Journal:  Pharmacogn Mag        ISSN: 0973-1296            Impact factor:   1.085


  19 in total

1.  A simple and sensitive method for the determination of hydroxylamine in fresh-water samples using hypochlorite followed by gas chromatography.

Authors:  Yasushi Seike; Ryoko Fukumori; Yukiko Senga; Hiroki Oka; Kaoru Fujinaga; Minoru Okumura
Journal:  Anal Sci       Date:  2004-01       Impact factor: 2.081

Review 2.  Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

Authors:  D L Bai; X C Tang; X C He
Journal:  Curr Med Chem       Date:  2000-03       Impact factor: 4.530

Review 3.  Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection.

Authors:  A J Vlietinck; T De Bruyne; S Apers; L A Pieters
Journal:  Planta Med       Date:  1998-03       Impact factor: 3.352

4.  Enhancement of griseofulvin release from liquisolid compacts.

Authors:  C M Hentzschel; M Alnaief; I Smirnova; A Sakmann; C S Leopold
Journal:  Eur J Pharm Biopharm       Date:  2011-08-09       Impact factor: 5.571

5.  A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Authors:  M S Rafii; S Walsh; J T Little; K Behan; B Reynolds; C Ward; S Jin; R Thomas; P S Aisen
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

6.  Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus.

Authors:  Kyoko Hayashi; Kazuto Narutaki; Yasuo Nagaoka; Toshimitsu Hayashi; Shinichi Uesato
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

7.  Antiproliferative and apoptotic effects of butyrolactone lignans from Arctium lappa on leukemic cells.

Authors:  T Matsumoto; K Hosono-Nishiyama; H Yamada
Journal:  Planta Med       Date:  2006-02       Impact factor: 3.352

8.  Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition.

Authors:  Min Kyung Cho; Young Pyo Jang; Young Choong Kim; Sang Geon Kim
Journal:  Int Immunopharmacol       Date:  2004-10       Impact factor: 4.932

9.  Formulation optimization of meloxicam sodium gel using response surface methodology.

Authors:  Jui-Sheng Chang; Yaw-Bin Huang; Sen-Sen Hou; Ren-Jiunn Wang; Pao-Chu Wu; Yi-Hung Tsai
Journal:  Int J Pharm       Date:  2007-01-28       Impact factor: 5.875

10.  Dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study.

Authors:  Curt T Dellavalle; Qian Xiao; Gong Yang; Xiao-Ou Shu; Briseis Aschebrook-Kilfoy; Wei Zheng; Hong Lan Li; Bu-Tian Ji; Nathaniel Rothman; Wong-Ho Chow; Yu-Tang Gao; Mary H Ward
Journal:  Int J Cancer       Date:  2013-11-29       Impact factor: 7.396

View more
  1 in total

1.  Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitro.

Authors:  Min Zhou; Guobing Li; Liancai Zhu; Huyue Zhou; Laichun Lu
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.